Biogena Group Invest AG (WBO:BIO) EPS (Basic): €0.07 (TTM As of Jan. 2026)


WBO:BIO Biogena Group Invest AG WBO:BIO
64 GF Score
Price €4.54
GF Value €3.45
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Biogena Group Invest AG EPS (Basic)?

Biogena Group Invest AG WBO:BIO -0.87% 64 EPS (Basic) is €0.07 as of Jan. 2026. GuruFocus rates WBO:BIO with a GF Score™ of 64/100 and a GF Value™ of €3.45 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Biogena Group Invest AG's basic earnings per share (Basic EPS) for the six months ended in Jan. 2026 was €0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2026 was €0.07.

Biogena Group Invest AG's EPS (Diluted) for the six months ended in Jan. 2026 was €0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was €0.07.

Biogena Group Invest AG's EPS without NRI for the six months ended in Jan. 2026 was €0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2026 was 0.07.

During the past 12 months, Biogena Group Invest AG's average EPS without NRIGrowth Rate was -10.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was -0.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Biogena Group Invest AG's highest 3-Year average EPS without NRI Growth Rate was -0.40% per year. The lowest was -23.30% per year. And the median was -9.50% per year.

Biogena Group Invest AG  (WBO:BIO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Biogena Group Invest AG EPS (Basic) Related Terms

Biogena Group Invest AG EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Biogena Group Invest AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogena Group Invest AG EPS (Basic) Chart

Biogena Group Invest AG Annual Data
Trend Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EPS (Basic)
Get a 7-Day Free Trial 0.18 0.08 0.04 0.08 0.07

Biogena Group Invest AG Semi-Annual Data
Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EPS (Basic) Get a 7-Day Free Trial 0.18 0.08 0.04 0.08 0.07
WBO:BIO
64GF Score
Biogena Group Invest AG WBO:BIO
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogena Group Invest AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Biogena Group Invest AG's Basic EPS for the fiscal year that ended in Jan. 2026 is calculated as

Basic EPS (A: Jan. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.293-0)/3.990
=0.07

Biogena Group Invest AG's Basic EPS for the quarter that ended in Jan. 2026 is calculated as

Basic EPS (Q: Jan. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.293-0)/3.990
=0.07

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 was €0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.07 mean?
Biogena Group Invest AG (WBO:BIO) has a EPS (Basic) of €0.07 as of Jan. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Biogena Group Invest AG and its competitors.
Is Biogena Group Invest AG's EPS (Basic) too high?
Biogena Group Invest AG's current EPS (Basic) is €0.07. Overall, Biogena Group Invest AG has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's EPS (Basic) compare to KHC and GIS?
Biogena Group Invest AG's EPS (Basic) of €0.07 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Consumer Packaged Goods company?
A good EPS (Basic) depends on the Consumer Packaged Goods industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Biogena Group Invest AG and its competitors. Biogena Group Invest AG's current EPS (Basic) is €0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.45, compared to a current price of €4.54 — trading 31.6% above its estimated fair value. The current EPS (Basic) is €0.07. Biogena Group Invest AG's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current EPS (Basic) is €0.07 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued. The current stock price of €4.54 is trading 31.6% above its estimated GF Value™ of €3.45. GuruFocus considers Biogena Group Invest AG to be Significantly Overvalued.

Key valuation signals for WBO:BIO:

  • EPS (Basic): €0.07
  • GF Value™: €3.45 vs. price of €4.54 (31.6% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biogena Group Invest AG Business Description

Address Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
64GF Score

Get the complete analysis for WBO:BIO

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.54
Price
€3.45
GF Value